AC Immune partner J&J pauses Alzheimer’s trial enrollment
J&JJ&J(US:JNJ) Seeking Alpha·2026-02-18 11:58

AC Immune (ACIU) has disclosed that its partner Janssen Pharmaceuticals of Johnson & Johnson (JNJ) has temporarily paused enrollments in a mid-stage trial for their jointly developed Alzheimer’s candidate ACI-35.030/JNJ-2056. The companies are advancing ACI-35.030/JNJ-2056 as part of a licensing ...

AC Immune partner J&J pauses Alzheimer’s trial enrollment - Reportify